Selenium supplementation is widely used for a broad range of autoimmune thyroid diseases, although it is only recommended for mild Graves’ orbitopathy. One study found that patients treated with ...

Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves' orbitopathy, ...

The prevalence of thyroid orbitopathy, compared with an estimate for the United Kingdom population, is examined in a large cohort of patients treated for periocular lymphoma. Clinical details were ...

Please provide your email address to receive an email when new articles are posted on . In adults with Graves’ disease, the risk for Graves’ orbitopathy may be associated with increased levels of ...

VICTORIA, British Columbia — The addition of nonsteroidal intravenous (IV) mycophenolate to the recommended therapy of IV methylprednisolone significantly improves severe Graves' orbitopathy, with ...

Initial thyroid-stimulating immunoglobulin (TSI) levels and early initiation of treatment were found to predict TSI normalization in a recent study published in BMC Ophthalmology by Park and ...

Background A 59-year-old woman with a history of nodular goiter developed thyrotoxic symptoms while on levothyroxine therapy. Her thyrotoxicosis persisted after levothyroxine withdrawal, so she was ...

Graves’ disease is the most common cause of hyperthyroid­ism and frequently causes changes to the eye and surrounding structures, including retraction of the eyelid, bulging of the eye, and restricted ...

DelveInsight’s “Graves’ Orbitopathy Pipeline Insight 2025” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Graves’ Orbitopathy pipeline landscape. It covers the ...

A collaborative program designed to treat thyroid eye disease (TED) at the University of Utah offers patients access to highly customized treatments—including a delicate endoscopic surgery at the John ...